Next Article in Journal
Marine Natural Meroterpenes: Synthesis and Antiproliferative Activity
Next Article in Special Issue
Structures, Biological Activities and Phylogenetic Relationships of Terpenoids from Marine Ciliates of the Genus Euplotes
Previous Article in Journal
Iodocionin, a Cytotoxic Iodinated Metabolite from the Mediterranean Ascidian Ciona edwardsii
Article Menu

Export Article

Open AccessReview
Mar. Drugs 2010, 8(2), 313-346;

Bioactive Sesterterpenes and Triterpenes from Marine Sponges: Occurrence and Pharmacological Significance

Institute of Pharmaceutical Biology and Biotechnology, Heinrich-Heine University, Universitaets-strasse 1, D-40225 Duesseldorf, Germany
State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100083, China
Department of Pharmacognosy and Phytochemistry, Faculty of Pharmacy, Ain-Shams University, Abbasia, Cairo, Egypt
Authors to whom correspondence should be addressed.
Received: 20 January 2010 / Revised: 5 February 2010 / Accepted: 20 February 2010 / Published: 23 February 2010
(This article belongs to the Special Issue Terpenoids of Marine Origin)
Full-Text   |   PDF [495 KB, uploaded 24 February 2015]


Marine ecosystems (>70% of the planet's surface) comprise a continuous resource of immeasurable biological activities and immense chemical entities. This diversity has provided a unique source of chemical compounds with potential bioactivities that could lead to potential new drug candidates. Many marine-living organisms are soft bodied and/or sessile. Consequently, they have developed toxic secondary metabolites or obtained them from microorganisms to defend themselves against predators [1]. For the last 30–40 years, marine invertebrates have been an attractive research topic for scientists all over the world. A relatively small number of marine plants, animals and microbes have yielded more than 15,000 natural products including numerous compounds with potential pharmaceutical potential. Some of these have already been launched on the pharmaceutical market such as Prialt® (ziconotide; potent analgesic) and Yondelis® (trabectedin or ET-743; antitumor) while others have entered clinical trials, e.g., alpidin and kahalalide F. Amongst the vast array of marine natural products, the terpenoids are one of the more commonly reported and discovered to date. Sesterterpenoids (C25) and triterpenoids (C30) are of frequent occurrence, particularly in marine sponges, and they show prominent bioactivities. In this review, we survey sesterterpenoids and triterpenoids obtained from marine sponges and highlight their bioactivities. View Full-Text
Keywords: sesterterpenoids; triterpenoids; marine sponges sesterterpenoids; triterpenoids; marine sponges
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Ebada, S.S.; Lin, W.; Proksch, P. Bioactive Sesterterpenes and Triterpenes from Marine Sponges: Occurrence and Pharmacological Significance. Mar. Drugs 2010, 8, 313-346.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top